1Weinberger MH, Roniker B, Krause SL, et al, Eplerenone, a Selective aldosterone blocker,in mild-to-moderate hypertension[J]. Am J Hypertens,2002,15(8):709-716.
2White WB, Carr AA, Krause S,et al. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension[J]. Am J Cardiol,2003,92(1) :38-42.
3Flack JM,Oparil S,Pratt JH, et al. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white pat ients[J]. J Am Coll Cardiol, 2003,2 ; 41 (7): 1148-1155.
4Williams GH, Burgess K, Kolloch RE, et al. Efficacy of eplerenone Versus enalapril as monotherapy in systemic hypertension[J]. Am J Cardiol,2004,93(8) :990-996.
5Krum H, Nolly H, Workman D, et al. Efficacy of eplerenone added to rennin-angiotensin blockade in hypertensive patients[J]. Hypertension,2002, 40(2) : 117-123.
6White WB, Duprez D, Sthillaire R, et al. Elects of the selective aldosterone blocker eplerenone Versus the calcium antagonist amlodipine in systolic hypertelnion [J]. Hypertebsion,2003,41 (5) : 1021-1026.
7Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction[J]. N Engl J Med, 2003,348 :1309-1321.
8Rudolph AE, Rocha R, McMahon EG. Aldosterone target organ protection by eplerenone. [J]. Mol Cell Endocrinol, 2004,217(1-2) : 229-238.
9Pitt B, Reichek N, Willeubrock R,et al. Effects of eplerenone,enalapril, and eplerenone/enatapril in patients with essential hypertension and left ventricular hypertrophy:the 4E-left ventricular hypertrophy study [J]. Circulation, 2003,108 ( 15 ) :1831-1838.
10Keidar S, Hayek T, Keplan M,et al. Effect of eplerenone, a selective aldosterone blocker, on blood pressue, serum and macrophage oxidative stress,and atheroselerosis in apolipoprotein Edeficient mice[J]. J Cardiovasc Pharmacol, 2003,41 (6) : 955-963. [p146]
3ZHANG JY, FAST DM, BREAU AP. A validated SPE-LC-MS/ MS assay for eplerenone and its hydrolyzed metabolite in human urine [J]. J Pharma Biomed Anal, 2003, 31 (1): 103-115.
4Cook CS, Zhang L, Ames GB, et al. Single and repeated dose pharmacokinetics of eplerenone, a selective aldosterone receptor blocker, in rats[J].Xenobiotica, 2003,33 (3) : 305-321.
5Ravis WR, Sica DA. Pharmaeokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment[J]. J Clin pharmacol, 2005,45 : 810-821.
6Zhang J, Fast D, Breau A. A validated SPE LC-MS/MS assay for eplerenone and its hydrolyzed metabolite in human urine [J]. J Pharm Bio Analysis,2003,31 : 103 -115.
7Zhang J,Fast. D,Breau A. Development and validation of a liq uid chromatography-tandem mass spectrometric assay for eplerenone and its hydrolyzed metabolite in human plasma[J]. J Chrom B, 2003,787:333-344.
